UPDATE 2-Schering buoyed by FDA priority cancer drug review
498388
German drug maker Schering AG (SCHG.DE: Quote , Profile , Research ) was boosted on Thursday as the U.S. Food and Drug Administration granted its Bonefos treatment "priority review" for preventing bone tumours ...
636079
New data presented today confirm that advanced lung cancer patients canlook forward to better-quality survival when treated with Alimta(R)(pemetrexed), a newly approved anticancer agent in the European Unioncompared with Taxotere(R) (docetaxel).
740280
The Food and Drug Administration approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.
518382
A new drug that fights a form of age-related macular degeneration (AMD), a leading cause of blindness in the elderly, won applause if not approval from a panel of advisors to the US Food and Drug Administration.
394537
A breakthrough cancer drug made by a Long Island company won federal approval late Thursday in a major victory for cancer patients and the region&#39;s budding biotech industry.
142281
FDA advisory panel gives the nod to its heart drug.
362336
By Thomas Ginsberg, The Philadelphia Inquirer  Dec. 19--Wyeth Pharmaceuticals said today that the FDA has agreed to conduct a fast-track review of the company's new kidney cancer-fighting drug, Torisel.
118432
The US Food and Drug Administration (FDA) has approved the Eli Lilly drug Alimta, for the treatment of advanced non-small cell lung cancer in previously treated patients.
311786
Abbott Laboratories Inc. said Tuesday it is seeking regulatory approval for a drug to treat advanced prostate cancer that has spread through the body.
519863
The company faces a pivotal clinical trial.
265727
GlaxoSmithKline said on Tuesday that U.S. health regulators granted a priority review to a capsule form of its drug Hycamtin for the treatment of relapsed small cell lung cancer.
589310
NORTH CHICAGO, Ill. -- Abbott Laboratories Inc. is seeking US regulatory approval for a drug to treat advanced-stage prostate cancer, the company announced Tuesday.
531621
Schering gets an expanded label and begins marketing another drug overseas.
280625
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol medicine Vytorin after a study showed it was no better than a generic drug in preventing the build-up of fatty plaque.
467984
The US Food and Drug Administration approved a new drug to treat patients with advanced lung cancer. It&#39;s called Alimta. Patients receive ten minute infusions of the drug every three weeks on an outpatient basis.
667096
The biotech's new cancer candidate passes phase 1 trials.
191337
GlaxoSmithKline won permission yesterday from the Food and Drug Administration to sell a tumor-growth inhibitor called Tykerb to treat breast cancer.